Seven months after injection, the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels remained within normal ranges (Fig. S11c and S11d), with no indications of hepatocellular injury or hepatocellular carcinoma (HCC) (Fig. S11e). This evidence concerns the gene GPT and hepatocellular carcinoma.